Forecasted · Cooperative Agreement
Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)
National Institutes of Health, Department of Health and Human Services
Key facts
Copied from the official Grants.gov record. Last verified October 29, 2026.
- Program name
- Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)
- Issuing agency
- National Institutes of Health (Department of Health and Human Services)
- Opportunity number
- PAR-27-009
- Funding type
- Cooperative Agreement
- Funding purpose
- Health
- Status
- Forecasted
- Application deadline
- Forecasted · estimated close January 25, 2027 (agency estimate)
- Agency estimates
- Estimated posting: November 25, 2026. Estimated award date: December 1, 2027. Estimates can change.
- Published award range
- Not published by the agency
- Cost sharing or match required
- No
- Eligible applicants (official categories)
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see Additional Information on Eligibility)
- Relevant to
- Businesses and NonprofitsHow we determined this: Grants.gov eligibility includes small businesses or for-profit organizations. Grants.gov eligibility includes nonprofit organizations.
- Geographic restrictions
- None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.
- Assistance Listing (CFDA)
- 93.393, 93.394, 93.395, 93.396
- Official source
- View on Grants.gov ↗
- Application URL
- www.grants.gov/search-results-detail/361606 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.
- Source identifier
- Grants.gov opportunity ID 361606 · Funding opportunity number PAR-27-009
- Posted
- March 24, 2026 · Source last updated March 24, 2026
- Last verified
- October 29, 2026 (against Grants.gov)
- Data completeness
- 92% of key fields published by the sourceNot published: published funding range.
- Record confidence
- mediumforecast — dates and amounts are agency estimates.
Eligibility details (from the agency)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Description (from the official listing)
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to continue to support the Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium, which coordinates research on prevention, diagnosis, treatment, and mechanisms of resistance in SCLC. The CC manages administrative activities, centralized databases, tissue banking and a virtual biospecimen resource, biostatistics and bioinformatics support, in vivo and in vitro model repositories, and communications and website operations for the Consortium. Since its establishment in response to the Recalcitrant Cancer Research Act, the Consortium has catalyzed SCLC-focused research and enabled major advances in molecular characterization, tumor heterogeneity, microenvironment and immune evasion, biomarker development, preclinical models, therapeutic strategies, and clinical translation. The current U24 CC, based at Sloan Kettering with collaborating institutions, organizes meetings, maintains extensive -omics and model resources, supports young investigators, and provides datasets and models to the research community. The reissue NOFO will support a five-year cooperative agreement to sustain these shared resources and collaborations. This is a Forecast for a single source that will invite application(s) from eligible organization(s) to apply. Please see the Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.
Agency contact
SCLC CC NOFO
SCLC-CU24@mail.nih.gov